Corpus Intelligence IC Memo — SEVEN RIVERS REGIONAL MEDICAL CENTER 2026-04-26 12:29 UTC
IC Memo — SEVEN RIVERS REGIONAL MEDICAL CENTER
Investment Committee Memorandum | FL | 121 beds | Grade B | EBITDA uplift $9.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SEVEN RIVERS REGIONAL MEDICAL CENTER

CCN 100249 | CITRUS, FL | 121 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

SEVEN RIVERS REGIONAL MEDICAL CENTER is a 121-bed suburban community hospital in CITRUS, FL with $124.2M in net patient revenue and a 13.1% operating margin. The hospital serves a payer mix of 34.4% Medicare, 0.9% Medicaid, and 64.7% commercial.

Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.1% to 20.4% (+736bps).

Net Revenue HCRIS$124.2M
Current EBITDA COMPUTED$16.2M
Operating Margin COMPUTED13.1%
Occupancy HCRIS61.9%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS10.4%
Distress Probability ML43.0%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
117
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 13.1% places it above the state median. Among 117 size-comparable peers (60-242 beds), the median margin is 5.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (60-242), prioritizing same-state peers. 117 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SEVEN RIVERS REGIONAL MEDICAL (Target)FL121$124.2M13.1%
MOFFITT CANCER CENTERFL218$1.91B16.0%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
HCA FL FT WALTON-DESTIN HOSPFL231$361.3M38.1%
ADVENTHEALTH WESLEY CHAPELFL169$360.1M17.0%
JUPITER MEDICAL CENTERFL242$333.2M-10.7%
ORLANDO HEALTH SOUTH LAKE HOSPFL167$331.8M7.2%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
ADVENTHEALTH SEBRINGFL204$279.7M-3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$79K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.5M
A/R Days Reduction
$1.5M
Clean Claim Rate
$79K
Total EBITDA Uplift$9.1M
Current EBITDA$16.2M
+ RCM Uplift+$9.1M
Pro Forma EBITDA$25.4M
Current Margin13.1%
Pro Forma Margin20.4%
WC Released (1x)$4.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$25.0M$198.4M7.95x51.4%
Base (11x exit)10.0x11.0x$25.0M$226.4M9.07x55.4%
Bull Case9.0x11.0x$22.5M$264.6M11.78x63.8%
Bull (12x exit)9.0x12.0x$22.5M$295.3M13.14x67.4%
Bear Case11.0x10.0x$27.5M$144.6M5.27x39.4%
Bear (11x exit)11.0x11.0x$27.5M$168.0M6.12x43.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 117 hospitals with 60-242 beds
  • Same-state prioritization (n=118)
  • Comp margins: P25=-6.5% / P50=5.0% / P75=15.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.